8WGT
Crystal structure of V30M-TTR in complex with compound 7
8WGT の概要
エントリーDOI | 10.2210/pdb8wgt/pdb |
分子名称 | Transthyretin, [4,7-bis(chloranyl)-2-ethyl-1-benzofuran-3-yl]-[3,5-bis(iodanyl)-4-oxidanyl-phenyl]methanone (3 entities in total) |
機能のキーワード | transthyretin, amyloidosis, inhibitor, benziodarone derivative, transport protein |
由来する生物種 | Homo sapiens (human) |
タンパク質・核酸の鎖数 | 2 |
化学式量合計 | 35859.11 |
構造登録者 | |
主引用文献 | Mizuguchi, M.,Nakagawa, Y.,Yokoyama, T.,Okada, T.,Fujii, K.,Takahashi, K.,Luan, N.N.T.,Nabeshima, Y.,Kanamitsu, K.,Nakagawa, S.,Yamakawa, S.,Ueda, M.,Ando, Y.,Toyooka, N. Development of Benziodarone Analogues with Enhanced Potency for Selective Binding to Transthyretin in Human Plasma. J.Med.Chem., 67:6987-7005, 2024 Cited by PubMed Abstract: Transthyretin amyloidosis is a fatal disorder caused by transthyretin amyloid aggregation. Stabilizing the native structure of transthyretin is an effective approach to inhibit amyloid aggregation. To develop kinetic stabilizers of transthyretin, it is crucial to explore compounds that selectively bind to transthyretin in plasma. Our recent findings demonstrated that the uricosuric agent benziodarone selectively binds to transthyretin in plasma. Here, we report the development of benziodarone analogues with enhanced potency for selective binding to transthyretin in plasma compared to benziodarone. These analogues featured substituents of chlorine, bromine, iodine, a methyl group, or a trifluoromethyl group, at the 4-position of the benzofuran ring. X-ray crystal structure analysis revealed that CH···O hydrogen bonds and a halogen bond are important for the binding of the compounds to the thyroxine-binding sites. The bioavailability of benziodarone analogues with 4-Br, 4-Cl, or 4-CH was comparable to that of tafamidis, a current therapeutic agent for transthyretin amyloidosis. PubMed: 38670538DOI: 10.1021/acs.jmedchem.3c02286 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.696 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード